Top

Published in:

01-01-2020 | Human Immunodeficiency Virus | Original Paper

Will We Get to Zero HIV Stigma in San Francisco?

Authors: Sofia Beltran, Yea-Hung Chen, Desmond Miller, Theresa Ick, Jessica Lin, Tracey Packer, Willi McFarland, Henry F. Raymond

Published in: AIDS and Behavior | Issue 1/2020

Abstract

Cities worldwide are striving to get to zero HIV stigma as a condition to get to zero new infections. We tracked an indicator of perceived HIV stigma across surveys of men who have sex with men (MSM) in San Francisco from 2011 to 2017. Little improvement in perceived HIV stigma was observed, from 22.3% (95% CI 18.7–26.3) of MSM agreeing with the statement “Most people would discriminate against someone with HIV” in 2011 to 21.0% (95% CI 17.5–24.9) in 2017 (χ² test for trend 0.252, p = 0.616). Success in ending the epidemic may flag without addressing the causes of HIV stigma.

UNAIDS. Getting to zero. 2010;5–34. http://www.unaids.org/sites/default/files/sub_landing/files/JC2034_UNAIDS_Strategy_en.pdf. Accessed 13 Sept 2018

Getting to zero San Francisco. http://www.gettingtozerosf.org. Accessed 13 Sept 2018

San Francisco Department of Public Health. HIV epidemiology annual report 2017. https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/AnnualReport2017-Green-20180904-Web.pdf. Accessed 13 Sept 2018

Rueda S, Mitra S, Chen S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453. https://doi.org/10.1136/bmjopen-2016-011453.CrossRefPubMedPubMedCentral

Tan RKJ. Internalized homophobia, HIV knowledge, and HIV/AIDS personal responsibility beliefs: correlates of HIV/AIDS discrimination among MSM in the context of institutionalized stigma. J Homosex. 2018;21:1–22.

Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, Tsai AC. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3Suppl 2):18640. https://doi.org/10.7448/ias.16.3.18640.CrossRefPubMedPubMedCentral

Logie CH, Jenkinson JIR, Earnshaw V, Tharao W, Loutfy MR. A structural equation model of HIV-related stigma, racial discrimination, housing insecurity and wellbeing among african and caribbean black women living with HIV in Ontario, Canada. PLoS ONE. 2016;11(9):e0162826. https://doi.org/10.1371/journal.pone.0162826.CrossRefPubMedPubMedCentral

MacKellar D, Valleroy L, Karon J, Lemp G, Janssen R. The Young Men’s Survey: methods for estimating HIV seroprevalence and risk factors among young men who have sex with men. Public Health Rep. 1996;111(Suppl 1):138–44.PubMedPubMedCentral

Raymond HF, Guigayoma J, Snowden J, Chen Y-H, McFarland W. Community levels of PrEP use among men who have sex with men by race/ethnicity, San Francisco, 2017. Conference of the American Public Health Associattion, 2018 [Abstract #2057].

10.

Liu H, Xu Y, Sun Y, Dumenci L. Measuring HIV stigma at the family level: psychometric assessment of the Chinese Courtesy Stigma Scales (CCSSs). PloS ONE. 2014;9(3):e92855. https://doi.org/10.1371/journal.pone.0092855.CrossRefPubMedPubMedCentral

11.

Hatzenbuehler ML. Structural stigma: research evidence and implications for psychological science. Am Psychol. 2013;71(8):742–51.CrossRef

12.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–77.CrossRef

Title: Will We Get to Zero HIV Stigma in San Francisco?
Authors: Sofia Beltran
Yea-Hung Chen
Desmond Miller
Theresa Ick
Jessica Lin
Tracey Packer
Willi McFarland
Henry F. Raymond
Publication date: 01-01-2020
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: AIDS and Behavior / Issue 1/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02434-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs –Miami, FL, 2018

The Relationship Between Discrimination and Missed HIV Care Appointments Among Women Living with HIV

The Effect of Social Networks and Social Constructions on HIV Risk Perceptions

Gender Non-affirmation from Cisgender Male Partners: Development and Validation of a Brief Stigma Scale for HIV Research with Transgender Men Who Have Sex with Men (Trans MSM)

Public Health, HIV Care and Prevention, Human Rights and Democracy at a Crossroad in Brazil

Correction to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials